AliveDx Suisse S.A. and Lavichem Sign Distribution Agreement for MosaiQ Diagnostic Solution in Northern Vietnam

 

Hanoi, Vietnam – May 2024 – AliveDx Suisse S.A., a pioneer in the field of medical diagnostics, and Lavichem Joint Stock Company, a leading microbiology manufacturer in Vietnam, have signed an exclusive distribution agreement, allowing Lavichem to distribute the advanced diagnostic solution MosaiQ in the Northern region of Vietnam. The agreement is effective immediately.

Expanding Access and Improving Health Care

This strategic partnership marks AliveDx’s commitment to expanding the reach and improving the quality of medical diagnostic services in Vietnam. The advanced MosaiQ solution uses multiplex microarray testing technology, streamlining workflows and delivering high efficiency, helping to shorten diagnostic times and improve treatment outcomes for patients. Mr. Manuel O. Méndez, CEO of AliveDx, shared: “We are delighted to partner with Lavichem, a reputable distributor in Northern Vietnam. This partnership will help us provide the MosaiQ diagnostic solution to clinicians effectively and cost-effectively, contributing to improving the quality of healthcare for people in the region.”

Lavichem – Strategic Partner

Lavichem, founded in 2010 and headquartered in Hanoi, is a leading manufacturer of microbiology in Vietnam. With its extensive experience and distribution network, Lavichem will play a key role in bringing the MosaiQ solution to clinicians and patients in the Northern region.

Ms. Huyen, Owner of Lavichem, affirmed: “We are honored to cooperate with AliveDx, a pioneer in the field of medical diagnostics. The MosaiQ solution will contribute to improving the diagnosis and treatment capacity for patients, while bringing economic benefits to healthcare providers. We believe that this cooperation will reap many successes and bring practical benefits to the community.”

For more information, please visit the website Lavichem.vn